The present invention relates to parstatin peptides, compositions comprising parstatin peptides and their use in the treatment of various disorders, including angiogenesis-related diseases, ocular neovascularization and related disease states, ischemia-reperfusion injury and myocardial-related disease states, and renal disorders.
